Cargando…
Folic Acid and Vitamin B12 Administration in CKD, Why Not?
Patients affected by chronic kidney disease (CKD) or end-stage renal disease (ESRD) experience a huge cardiovascular risk and cardiovascular events represent the leading causes of death. Since traditional risk factors cannot fully explain such increased cardiovascular risk, interest in non-tradition...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413093/ https://www.ncbi.nlm.nih.gov/pubmed/30781775 http://dx.doi.org/10.3390/nu11020383 |